Battea Q4 2022 Client Newsletter
Battea 2022 Client Newsletter: Settlement Funds with Imminent Claims Filing Deadlines
[table “” not found /]
SIBOR SOR SETTLEMENT:
ELIGIBLE CLASS: All persons or entities that engaged in U.S.-based transactions in financial instruments that were priced, benchmarked, and/or settled based on SIBOR and/or SOR at any time from at least January 1, 2007 through December 31, 2011.
ELIGIBLE INSTRUMENTS: SIBOR/SOR-based derivatives: All financial instruments that were priced, benchmarked, and/or settled based on SIBOR and/or SOR and that were transacted in U.S.-based transactions, including over the counter instruments such as interest rate swaps, forward rate agreements, and foreign exchange swaps and forwards.
* NOTE: Battea is requesting ALL SIBOR/SOR based derivatives trading data. Battea will file and track the claim to ensure you will receive your maximum recovery possible.
[table “” not found /]
CREDIT ACCEPTANCE CORP.:
ELIGIBLE CLASS: All persons and entities who purchased or otherwise acquired the publicly traded securities of Credit Acceptance Corporation between May 4, 2018 and August 28, 2020.
ELIGIBLE INSTRUMENTS: Credit Acceptance Corporation (“CACC”) common shares.
COVETRUS INC.:
ELIGIBLE CLASS: All persons or entities that purchased or otherwise acquired Covetrus common stock from February 8, 2019 through August 12, 201.
ELIGIBLE INSTRUMENTS: Covetrus (“CVET”) common stock.
AMTRUST PREFERRED STOCK LITIGATION:
ELIGIBLE CLASS: All persons who purchased any of the AmTrust’s six series of preferred stock on the open market on a U.S. stock exchange during the period January 22, 2018 through January 18, 2019.
ELIGIBLE INSTRUMENTS: AmTrust (“AFSIA”) preferred stock.
EVOLENT HEALTH, INC.:
ELIGIBLE CLASS: All persons and entities other than Defendants who purchased or otherwise acquired the publicly traded securities of Evolent Health Inc. between January 10, 2018 and May 28, 2019.
ELIGIBLE INSTRUMENTS: Evolent Health Inc. (“EVH”) common shares.
INOVIO PHARMACEUTICALS:
ELIGIBLE CLASS: All persons and entities other than Defendants who purchased or otherwise acquired the publicly traded securities of Inovio Pharmaceuticals, Inc. between February 14, 2020 and August 10, 2020.
ELIGIBLE INSTRUMENTS: Inovio Pharmaceuticals, Inc. (“IVO”) common shares.
SEALED AIR CORPORATION:
ELIGIBLE CLASS: All persons and entities other than Defendants who purchased or otherwise acquired the publicly traded securities of Sealed Air Corporation between November 17, 2014 and June 20, 2019.
ELIGIBLE INSTRUMENTS: Sealed Air Corporation (“SEE”) common shares.
VANDA PHARMACEUTICALS:
ELIGIBLE CLASS: All persons and entities other than Defendants who purchased or otherwise acquired the publicly traded securities of Vanda Pharmaceuticals between November 4, 2015 and February 11, 2019.
ELIGIBLE INSTRUMENTS: Vanda Pharmaceuticals (“VNDA”) common shares.
DOUYU INTERNATIONAL HOLDINGS:
ELIGIBLE CLASS: All persons and entities who purchased or otherwise acquired American Depositary Shares of DouYu International Holdings Limited, pursuant and/or traceable to the Company’s IPO on July 16, 2019 , and/or between July 17, 2019 and January 21, 2020.
ELIGIBLE INSTRUMENTS: DouYu International Holdings Limited American Depositary Shares.
ORACLE CORP.:
ELIGIBLE CLASS: All persons or entities who purchased or otherwise acquired securities of Oracle Corporation during the period from May 10, 2017 to June 20, 2018.
ELIGIBLE INSTRUMENTS: Oracle Corporation (“ORCL”) common shares.
Battea 2022 Client Newsletter: Recent International Litigation Updates
Petrobras “Lava Jato” Litigation
The Stichting Petrobras Compensation Foundation (SPCF) is representing damaged investors who transacted on the primary market in Brazil and on linked markets around the world (excluding the ADRs traded on the NYSE) and who held non-US bonds, a class of investors with estimated damages in excess of $15 billion. Oral hearings for injunctive relief commence January 17, 2023. In the event of a favorable ruling, SPCF will immediately file individual damages litigations on behalf of all ISAF-registered claimant/plaintiffs. To preserve standing, and to facilitate a quick turnaround on damages cases filed with the Court, eligible claimants are advised to register with ISAF prior to the oral hearings. Battea is requesting that all clients register their claims by January 13, 2023.
The Foundation urges continued participation from investors who have not yet joined the damaged investor coalition. For more information, contact ISAF today: https://isafmanagement.com/petrobras-case/case-participation.
Battea 2022 Client Newsletter: Battea in the News
Battea Global Litigation Research, Inc. Whitepaper
“Trade Spoofing: Legal Liabilities and Financial Recoveries are No Joke” by David Abel, External Counsel, In Cooperation with Battea Global Litigation Research, Inc, highlights how spoofing can carry criminal and civil penalties depending on which laws the person is accused of violating. Download this new Battea Global Litigation Research, Inc. whitepaper today to view the full report.
M&A Today® Global Awards 2023
Battea has been chosen as the recipient of the Best in Hedge Fund Securities Class Action Settlement Recovery – 2023 by Global 100®. Battea is receiving this award for the fifth straight year and its selection was chosen by the nearly 300,000 professionals in senior leadership positions, including C-suite and directors.
Global 100® & M&A Today® Global Awards 2023
Battea has been chosen as the recipient of the Best in Investor Settlement Recovery by M&A Today®. This incredible achievement highlights Battea for having a high pedigree in managing the most complex data sets, continuous investments in innovation, a supreme level of service, and the overall value the firm provides in this tough ever-changing industry. With this award, Battea demonstrates unquestionable abilities and endorsements from both clients and peers.
Reminder: The main ingredient in a successful filing is the data – in this case your data!
If you have any questions about how you can ensure that we have all of your eligible transactional data, please contact your customer service representative or call at (203) 987-4949.